{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:09:49Z","timestamp":1787314189259,"version":"build-2736575974"},"reference-count":104,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bbadis.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T02:20:04Z","timestamp":1560219604000},"page":"165489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Stem cell therapy in heart failure: Where do we stand today?"],"prefix":"10.1016","volume":"1866","author":[{"given":"Nandini","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Gongora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.06.003_bb0005","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0010","first-page":"e282","volume":"134","author":"Yancy","year":"2016","journal-title":"America Circulation"},{"key":"#cr-split#-10.1016\/j.bbadis.2019.06.003_bb0015.1","doi-asserted-by":"crossref","unstructured":"C.W. Yancy, M. Jessup, B. Bozkurt, et al 2017 ACC\/AHA\/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure","DOI":"10.1016\/j.cardfail.2017.04.014"},{"key":"#cr-split#-10.1016\/j.bbadis.2019.06.003_bb0015.2","doi-asserted-by":"crossref","unstructured":"Circulation 2017;136:e137-e161. DOI: https:\/\/doi.org\/10.1161\/CIR.0000000000000509.","DOI":"10.1161\/CIR.0000000000000509"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0025","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20132018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.healun.2009.02.015","article-title":"INTERMACS profiles of advanced heart failure: the current picture","volume":"28","author":"Stevenson","year":"2009","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite cells and the muscle stem cell niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/eurheartj\/ehp342","article-title":"Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction","volume":"31","author":"Gavira","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","article-title":"Autologous skeletal myoblast transplantation for severe post infarction left ventricular dysfunction","volume":"41","author":"Menasche","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0050","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.jacc.2003.06.017","article-title":"Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up","volume":"42","author":"Smits","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0055","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.ehj.2003.09.012","article-title":"Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction","volume":"24","author":"Herreros","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0060","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ahj.2004.03.043","article-title":"Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up","volume":"148","author":"Siminiak","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.105.547810","article-title":"Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up","volume":"112","author":"Dib","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jtcvs.2005.11.030","article-title":"Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up","volume":"131","author":"Gavira","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0075","doi-asserted-by":"crossref","unstructured":"Veltman CE, Soliman OII, Geleijnse ML et al., Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. Eur. Heart J. 2008; 29: 1386\u20131396.doi.org\/https:\/\/doi.org\/10.1093\/eurhearti\/ehn171","DOI":"10.1093\/eurheartj\/ehn171"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jmcc.2001.1507","article-title":"Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting","volume":"34","author":"Reinecke","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0085","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1073\/pnas.1232447100","article-title":"Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host","volume":"100","author":"Leobon","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.RES.0000174794.22491.a0","article-title":"Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation","volume":"97","author":"Abraham","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0095","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/icvts\/ivt434","article-title":"Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease","volume":"18","author":"Brickwedel","year":"2014","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0110","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.stem.2010.06.015","article-title":"Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells","volume":"7","author":"Guenther","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jcmm.12062","article-title":"L\u00fc S et The tumourigenicity of iPS cells and their differentiated derivates","volume":"17","author":"Liu","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"130","key":"10.1016\/j.bbadis.2019.06.003_bb0125","doi-asserted-by":"crossref","first-page":"130ra47","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40169-016-0116-3","article-title":"Therapeutic use of stem cells for cardiovascular disease","volume":"5","author":"Faiella W, Atoui R","year":"2016","journal-title":"Clin Transl Med."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gendis.2014.07.003","article-title":"The potential and challenges of using stem cells for cardiovascular repair and regeneration","volume":"1","author":"Sun","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature02460","article-title":"Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium","volume":"428","author":"Balsam","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0145","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2009.02.051","article-title":"The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction","volume":"53","author":"Yousef","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0150","doi-asserted-by":"crossref","unstructured":"Pittenger MF, Martin BJ, \u201cMesenchymal stem cells and their potential as cardiac therapeutics Circulation Research 2004;95 : 9\u201320. DOI 101.1161\/01.RES.0000135902.99383.6f.","DOI":"10.1161\/01.RES.0000135902.99383.6f"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0155","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2009.08.092","article-title":"Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction","volume":"55","author":"Armi\u00f1\u00e1n","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0170","first-page":"593","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk the New England","volume":"348","author":"Hill","year":"2003","journal-title":"J. Med."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.RES.87.9.728","article-title":"Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation","volume":"87","author":"Crosby","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0180","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"8","author":"Karantalis","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0185","doi-asserted-by":"crossref","unstructured":"Aggarwal S, Pittenger MF Human mesenchymal stem cells modulate allogeneic immune cell responses 2005; Blood 105: 1815\u2013182. DOI:https:\/\/doi.org\/10.1182\/blood-2004-04-1559.","DOI":"10.1182\/blood-2004-04-1559"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0190","first-page":"272","article-title":"Torre-Amione G","volume":"17","author":"Vrtovec","year":"2011","journal-title":"Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathyJ Card Fail."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0200","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejheart.2008.03.017","article-title":"Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction","volume":"10","author":"Mazo","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0205","doi-asserted-by":"crossref","first-page":"H1020","DOI":"10.1152\/ajpheart.01082.2008","article-title":"Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts","volume":"297","author":"Wang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2014.03.022","article-title":"Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE trial","volume":"168","author":"Perin","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0215","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0220","doi-asserted-by":"crossref","unstructured":"Ott HC, Matthiesen TS, Brechtken J et al. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells Nature Clinical Practice Cardiovascular Medicine 2007; 4, suppl 1: S27\u2013S39, 2007. DOI:https:\/\/doi.org\/10.1038\/ncpcardio0771.","DOI":"10.1038\/ncpcardio0771"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0225","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.115.307647","volume":"118","author":"Tang","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0235","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction : evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-derived aUtologous stem CElls to reverse ventricUlar dySfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0240","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0245","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.yjmcc.2003.09.011","article-title":"Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium","volume":"35","author":"Fijnvandraat","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0008-6363(03)00246-3","article-title":"Development of heart muscle-cell diversity: a help or a hindrance for phenotyping embryonic stem cell-derived cardiomyocytes","volume":"58","author":"Fijnvandraat","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0255","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ar.a.20388","article-title":"Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells The Anatomical Record\u2014Part A","volume":"288","author":"Nelson","year":"2006","journal-title":"Discoveries in Molecular, Cellular, and Evolutionary Biology"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0260","first-page":"33","article-title":"Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes","volume":"4","author":"Qiao","year":"2011","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0265","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature07040","article-title":"Stem-cell-based therapy and lessons from the heart","volume":"453","author":"Passier","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0270","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fj.06-6769com","article-title":"Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response","volume":"21","author":"Nussbaum","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0275","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0285","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Sch\u00e4chinger","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0290","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0295","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/eurheartj\/ehn436","article-title":"Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction","volume":"29","author":"Huikuri","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0300","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.athoracsur.2008.08.068","article-title":"Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery","volume":"86","author":"Zhao","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0305","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ncpcardio1321","article-title":"Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone","volume":"5","author":"Ang","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0310","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"etal., A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0315","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12265-009-9123-8","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study","volume":"3","author":"Pokushalov","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0320","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/eurheartj\/ehq449","volume":"32","author":"Hirsch","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0325","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0330","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.jacc.2011.01.037","volume":"57","author":"Hu","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0335","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0340","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Seeger FH effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0345","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12265-014-9580-6","article-title":"Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF)","volume":"7","author":"Santoso","year":"2014","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0350","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0355","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.healun.2014.02.009","article-title":"Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass","volume":"33","author":"P\u00e4til\u00e4","year":"2014","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0360","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12015-015-9601-0","article-title":"Human umbilical cord mesenchymal stromal cell transplantation in myocardial ischemia (HUC-HEART trial). A study protocol of a phase 1\/2, controlled and randomized trial in combination with coronary artery bypass grafting","volume":"11","author":"Can A Ulus","year":"2015","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0365","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/eurheartj\/ehv254","article-title":"Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial","volume":"36","author":"Chung","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0370","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ejhf.676","article-title":"An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial","volume":"19","author":"Choudhury","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0375","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","article-title":"Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the TRIDENT study)","volume":"121","author":"Florea","year":"2017","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2019.06.003_bb0380","volume":"6","author":"Miyagawa","year":"2017","journal-title":"Phase I clinical trial of autologous stem cell\u2013sheet transplantation therapy for treating cardiomyopathy J Am Heart Assoc."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0385","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-018-0969-z","article-title":"Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)","volume":"9","author":"Bassetti","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0390","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/clc.22882","article-title":"Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: a multicenter, double-blind randomized trial","volume":"41","author":"Nicolau","year":"2018","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0395","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.118.312978","article-title":"Rationale and design of the CONCERT-HF trial (combination of mesenchymal and c-kit+ cardiac stem cells as regenerative therapy for heart failure)","volume":"122","author":"Bolli","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0400","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jtcvs.2016.07.067","article-title":"The IMPACT-CABG trial: a multicenter, randomized clinical trial of CD133+ stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy","volume":"152","author":"Noiseux","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0405","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehv493","article-title":"A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial","volume":"37","author":"Choudry","year":"2016","journal-title":"Eur. Heart J."},{"issue":"11 suppl 1","key":"10.1016\/j.bbadis.2019.06.003_bb0410","first-page":"S54","article-title":"Loughran JH, et al Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0415","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023","volume":"2","author":"Fischer-Rasokat","year":"2009","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0420","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2009.11.070","article-title":"The ABCD (autologous bone marrow cells in dilated cardiomyopathy) trial","volume":"55","author":"Seth","year":"2010","journal-title":"a long-term follow-up study J Am Coll Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0425","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2008.06.002","article-title":"Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non-ischemic refractory heart failure","volume":"138","author":"Bocchi","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0430","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.bbadis.2019.06.003_bb0435","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3727\/096368916X691295","article-title":"The ixCELL-DCM trial: rationale and design","volume":"25","author":"Henry","year":"2016","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0440","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","article-title":"Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II-A randomized trial","volume":"120","author":"Butler","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0445","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM","volume":"69","author":"Hare","year":"2017","journal-title":"Trial J Am Coll Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0450","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.16-328","article-title":"A randomized comparative study on the efficacy of intracoronary infusion of autologous bone marrow mononuclear cells and mesenchymal stem cells in patients with dilated cardiomyopathy","volume":"58","author":"Xiao","year":"2017","journal-title":"Int. Heart J."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0455","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0460","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.106.671545","volume":"116","author":"Erbs","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0465","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.hlc.2013.01.013","article-title":"The return of the normal heart: resolution of cardiac amyloidosis after chemotherapy and bone marrow transplantation","volume":"22","author":"Fitzgerald","year":"2013","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0470","first-page":"53","article-title":"Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors","volume":"14","author":"Fitzgerald","year":"2017","journal-title":"Int J Cardiol Heart Vasc."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0475","first-page":"1823","volume":"24","author":"Nguyen","year":"2018","journal-title":"Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisBiol Blood Marrow Transplant."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0480","first-page":"106","article-title":"Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study","volume":"32","author":"Baughman","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0485","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-1084","article-title":"Diabetes impairs stem cell and proangiogenic cell mobilization in humans","volume":"36","author":"Fadini","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2019.06.003_bb0490","first-page":"892","article-title":"Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease","volume":"168","author":"Fadini","year":"2013","journal-title":"a meta-regression analysis. Int J Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0495","first-page":"635","article-title":"Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in \"no-option\" patients","volume":"61","author":"P1","year":"2008","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0500","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacc.2004.03.037","article-title":"Insulin resistance in idiopathic dilated cardiomyopathy","volume":"44","author":"Witteles","year":"2004","journal-title":"a possible etiologic link J Am Coll Cardiol."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0505","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5966\/sctm.2015-0172","article-title":"Efficacy of CD34+ stem cell therapy in nonischemic dilated cardiomyopathy is absent in patients with diabetes but preserved in patients with insulin resistance","volume":"5","author":"Vrtovec","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0510","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11671-009-9292-z","article-title":"Advances and prospect of nanotechnology in stem cells","volume":"4","author":"Wang","year":"2009","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bbadis.2019.06.003_bb0515","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14797\/mdcj-8-1-28","article-title":"Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications","volume":"8","author":"La Francesca","year":"2012","journal-title":"Methodist Debakey Cardiovasc J."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919301966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919301966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:50:10Z","timestamp":1760417410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443919301966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0925443919301966"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.003","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell therapy in heart failure: Where do we stand today?","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165489"}}